The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma episode artwork

EPISODE · Aug 26, 2014 · 12 MIN

The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma

from Journal of Clinical Oncology (JCO) Podcast

This podcast reviews the publication of the RESORT manuscript, and puts these results into context with the recently published Ardeshna trial of rituximab vs. observation in follicular lymphoma, concluding that there is no longer a role for rituximab maintenance in low tumor burden follicular lymphoma.

Episode metadata supplied by the publisher feed · Published Aug 26, 2014

Embed this episode

NOW PLAYING

The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma

0:00 12:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 12 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on August 26, 2014.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!